These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 26722437)
1. UCH-L1 involved in regulating the degradation of EGFR and promoting malignant properties in drug-resistant breast cancer. Jin Y; Zhang W; Xu J; Wang H; Zhang Z; Chu C; Liu X; Zou Q Int J Clin Exp Pathol; 2015; 8(10):12500-8. PubMed ID: 26722437 [TBL] [Abstract][Full Text] [Related]
2. Over-expression of ubiquitin carboxy terminal hydrolase-L1 induces apoptosis in breast cancer cells. Wang WJ; Li QQ; Xu JD; Cao XX; Li HX; Tang F; Chen Q; Yang JM; Xu ZD; Liu XP Int J Oncol; 2008 Nov; 33(5):1037-45. PubMed ID: 18949367 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of ubiquitin carboxyl terminal hydrolase-L1 enhances multidrug resistance and invasion/metastasis in breast cancer by activating the MAPK/Erk signaling pathway. Wang W; Zou L; Zhou D; Zhou Z; Tang F; Xu Z; Liu X Mol Carcinog; 2016 Sep; 55(9):1329-42. PubMed ID: 26293643 [TBL] [Abstract][Full Text] [Related]
4. EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P-gp substrates in vitro and in vivo. Jin Y; Zhang W; Wang H; Zhang Z; Chu C; Liu X; Zou Q Oncol Rep; 2016 Feb; 35(2):771-8. PubMed ID: 26718028 [TBL] [Abstract][Full Text] [Related]
5. Interaction between CD147 and P-glycoprotein and their regulation by ubiquitination in breast cancer cells. Wang WJ; Li QQ; Xu JD; Cao XX; Li HX; Tang F; Chen Q; Yang JM; Xu ZD; Liu XP Chemotherapy; 2008; 54(4):291-301. PubMed ID: 18689982 [TBL] [Abstract][Full Text] [Related]
6. UCH-L1-containing exosomes mediate chemotherapeutic resistance transfer in breast cancer. Ning K; Wang T; Sun X; Zhang P; Chen Y; Jin J; Hua D J Surg Oncol; 2017 Jun; 115(8):932-940. PubMed ID: 28334432 [TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients. Schröder C; Milde-Langosch K; Gebauer F; Schmid K; Mueller V; Wirtz RM; Meyer-Schwesinger C; Schlüter H; Sauter G; Schumacher U J Cancer Res Clin Oncol; 2013 Oct; 139(10):1745-55. PubMed ID: 23996067 [TBL] [Abstract][Full Text] [Related]
8. UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer. Chen XS; Wang KS; Guo W; Li LY; Yu P; Sun XY; Wang HY; Guan YD; Tao YG; Ding BN; Yin MZ; Ren XC; Zhang Y; Chen CS; Ye YC; Yang JM; Cheng Y Theranostics; 2020; 10(4):1833-1848. PubMed ID: 32042339 [No Abstract] [Full Text] [Related]
9. Involvement of EGFR in the promotion of malignant properties in multidrug resistant breast cancer cells. Xu JW; Li QQ; Tao LL; Cheng YY; Yu J; Chen Q; Liu XP; Xu ZD Int J Oncol; 2011 Dec; 39(6):1501-9. PubMed ID: 21805028 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance. Lien HC; Wang CC; Lin CH; Lu YS; Huang CS; Hsiao LP; Yao YT Hum Pathol; 2013 Sep; 44(9):1838-48. PubMed ID: 23664488 [TBL] [Abstract][Full Text] [Related]
11. CD44/cellular prion protein interact in multidrug resistant breast cancer cells and correlate with responses to neoadjuvant chemotherapy in breast cancer patients. Cheng Y; Tao L; Xu J; Li Q; Yu J; Jin Y; Chen Q; Xu Z; Zou Q; Liu X Mol Carcinog; 2014 Sep; 53(9):686-97. PubMed ID: 23681900 [TBL] [Abstract][Full Text] [Related]
12. Potential prognostic marker ubiquitin carboxyl-terminal hydrolase-L1 does not predict patient survival in non-small cell lung carcinoma. Orr KS; Shi Z; Brown WM; O'Hagan KA; Lappin TR; Maxwell P; Percy MJ J Exp Clin Cancer Res; 2011 Aug; 30(1):79. PubMed ID: 21878121 [TBL] [Abstract][Full Text] [Related]
13. UCH-L1 promotes invasion of breast cancer cells through activating Akt signaling pathway. Luo Y; He J; Yang C; Orange M; Ren X; Blair N; Tan T; Yang JM; Zhu H J Cell Biochem; 2018 Jan; 119(1):691-700. PubMed ID: 28636190 [TBL] [Abstract][Full Text] [Related]
14. Ubiquitin C-terminal hydrolase-L1 increases cancer cell invasion by modulating hydrogen peroxide generated via NADPH oxidase 4. Kim HJ; Magesh V; Lee JJ; Kim S; Knaus UG; Lee KJ Oncotarget; 2015 Jun; 6(18):16287-303. PubMed ID: 25915537 [TBL] [Abstract][Full Text] [Related]
15. Potentiation of ATP-induced currents due to the activation of P2X receptors by ubiquitin carboxy-terminal hydrolase L1. Manago Y; Kanahori Y; Shimada A; Sato A; Amano T; Sato-Sano Y; Setsuie R; Sakurai M; Aoki S; Wang YL; Osaka H; Wada K; Noda M J Neurochem; 2005 Mar; 92(5):1061-72. PubMed ID: 15715657 [TBL] [Abstract][Full Text] [Related]
16. UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma. Yang H; Zhang C; Fang S; Ou R; Li W; Xu Y Int J Clin Exp Pathol; 2015; 8(11):13957-67. PubMed ID: 26823707 [TBL] [Abstract][Full Text] [Related]
17. High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer. Miyoshi Y; Nakayama S; Torikoshi Y; Tanaka S; Ishihara H; Taguchi T; Tamaki Y; Noguchi S Cancer Sci; 2006 Jun; 97(6):523-9. PubMed ID: 16734731 [TBL] [Abstract][Full Text] [Related]
18. β-arrestin 2 is associated with multidrug resistance in breast cancer cells through regulating MDR1 gene expression. Jing X; Zhang H; Hu J; Su P; Zhang W; Jia M; Cheng H; Li W; Zhou G Int J Clin Exp Pathol; 2015; 8(2):1354-63. PubMed ID: 25973019 [TBL] [Abstract][Full Text] [Related]
19. Ubiquitin C-terminal hydrolase-L1 (Uch-L1) correlates with gonadal transformation in the rice field eel. Sun J; Shang X; Tian Y; Zhao W; He Y; Chen K; Cheng H; Zhou R FEBS J; 2008 Jan; 275(2):242-9. PubMed ID: 18076650 [TBL] [Abstract][Full Text] [Related]
20. Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy. Meyer-Schwesinger C; Meyer TN; Sievert H; Hoxha E; Sachs M; Klupp EM; Münster S; Balabanov S; Carrier L; Helmchen U; Thaiss F; Stahl RA Am J Pathol; 2011 May; 178(5):2044-57. PubMed ID: 21514420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]